Replies to post #106825 on Biotech Values

[WID]

M-enoxaparin sales of $292 million.

o Sandoz launches enoxaparin outpacing all recent injectables launches in the US; achieves enoxaparin sales of USD 292 million

See the link below:

http://www.novartis.com/downloads/investors/sales-results/Q3-2010-media-release_EN.pdf